Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
ASSETS   CURRENT ASSETS:    
Cash and cash equivalents $ 14,315,000 $ 16,896,000
Marketable securities, at fair value 27,201,000 28,571,000
Other current assets 141,000 206,000
  TOTAL CURRENT ASSETS 41,657,000 45,673,000
  OTHER ASSETS:    
Patents, net of accumulated amortization 1,236,000 1,326,000
Equity investment 3,636,000 5,249,000
Operating leases right-of-use asset 43,000 16,000
Security deposit 13,000 13,000
  Total Other Assets 4,928,000 6,604,000
  TOTAL ASSETS 46,585,000 52,277,000
  LIABILITIES AND STOCKHOLDERS’ EQUITY:   CURRENT LIABILITIES:    
Accounts payable 371,000 125,000
Accrued payroll 6,000 378,000
Other accrued expenses 182,000 297,000
Operating lease obligation, current 40,000 23,000
  Total Current Liabilities 599,000 823,000
  LONG TERM LIABILITIES:    
Deferred tax liability 407,000 762,000
  TOTAL LIABILITIES 1,006,000 1,585,000
  STOCKHOLDERS’ EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at September 30, 2024 and December 31, 2023
Common stock, $0.01 par value; authorized 50,000,000 shares;  23,110,495 and 23,553,908 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 231,000 235,000
Additional paid-in capital 67,757,000 67,446,000
Accumulated deficit (22,409,000) (16,989,000)
TOTAL STOCKHOLDERS’ EQUITY 45,579,000 50,692,000
  TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 46,585,000 $ 52,277,000